DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,798 filers reported holding DANAHER CORPORATION in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,075,862 | +3.3% | 20,461 | -0.1% | 0.18% | +7.9% |
Q2 2023 | $4,915,422 | -5.4% | 20,483 | -0.7% | 0.16% | -8.9% |
Q1 2023 | $5,198,559 | -2.0% | 20,628 | +3.2% | 0.18% | -6.2% |
Q4 2022 | $5,302,811 | -22.9% | 19,981 | -25.0% | 0.19% | -25.6% |
Q3 2022 | $6,879,000 | +22.5% | 26,637 | +32.5% | 0.26% | +23.4% |
Q2 2022 | $5,615,000 | -5.3% | 20,105 | -0.5% | 0.21% | +11.2% |
Q1 2022 | $5,928,000 | -9.8% | 20,210 | +1.2% | 0.19% | -4.1% |
Q4 2021 | $6,571,000 | +4.0% | 19,975 | -3.8% | 0.20% | -3.4% |
Q3 2021 | $6,321,000 | +10.2% | 20,764 | -2.9% | 0.20% | +10.9% |
Q2 2021 | $5,736,000 | +22.3% | 21,375 | +2.6% | 0.18% | +15.8% |
Q1 2021 | $4,690,000 | -10.3% | 20,836 | -11.4% | 0.16% | -15.1% |
Q4 2020 | $5,226,000 | +1.2% | 23,525 | -1.9% | 0.19% | -12.7% |
Q3 2020 | $5,162,000 | +18.8% | 23,971 | -2.4% | 0.21% | +10.9% |
Q2 2020 | $4,345,000 | – | 24,571 | – | 0.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
Third Point | 2,900,000 | $954,129,000 | 6.66% |
Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |